Your browser doesn't support javascript.
loading
MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma.
Li, Jenny J; Zhang, Xiaoling; Sankar, Neil; Espiritu, Lynn; Redkar, Sanjeev; Yu, Guo-Liang; Kizilbash, Sani H.
Affiliation
  • Li JJ; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
  • Zhang X; Apollomics Inc, Foster City, CA.
  • Sankar N; Apollomics Inc, Foster City, CA.
  • Espiritu L; Apollomics Inc, Foster City, CA.
  • Redkar S; Apollomics Inc, Foster City, CA.
  • Yu GL; Apollomics Inc, Foster City, CA.
  • Kizilbash SH; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
JCO Precis Oncol ; 6: e2200096, 2022 06.
Article in En | MEDLINE | ID: mdl-35675576
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurilemmoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurilemmoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2022 Document type: Article Affiliation country: Country of publication: